Furthermore, it was recently shown that PTENR130Q mutants tend to accumulate at the cell periphery where they form leading edges that increase tumor invasiveness and further activate the PI3K/AKT signaling axis [122]. The gene discussed is PIK3CA; the disease is neoplasm.